Nasdaq has suspended trading in Foamix Pharmaceuticals (FOMX -2.5%)
pending the release of news. In this case, it pertains to the FDA’s
expected decision on its application for acne foam FMX101 today (the
actual PDUFA date is Sunday, October 20).
https://seekingalpha.com/news/3507025-foamix-shares-halted-pending-news
https://seekingalpha.com/news/3507025-foamix-shares-halted-pending-news
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.